Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-01-24
1992-01-21
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514461, 514462, 514467, 549 64, 549313, 549370, 549448, A61K 31335, C07D33334
Patent
active
050828592
ABSTRACT:
Derivatives of benzocycloalkenyldihydroxyalkanoic acids, inhibitors of HMG CoA reductase, antagonists of thromoboxane A.sub.2 receptors and antifungals, denoted by the formula I ##STR1## in which X=CH.sub.2, O or S; R.sub.1 and R.sub.2, identical or different, =H, C.sub.1-3 alkyl or together from a --(CH.sub.2).sub.n -- chain (n=4,5) optionally substituted symmetrically by one or two C.sub.1-3 alkyl radicals.
R.sub.3 and R.sub.4, identical or different, =H, CF.sub.3, halogen (Cl, F, Br), C.sub.1-5 N,N-dialkylamino, C.sub.1-4 alkyl, C.sub.1-5 -alkoxy, C.sub.1-3 alkylthio, or phenyl optionally substituted by at most two substitutents which may be identical or different and may denote C.sub.1-3 alkyl or C.sub.1-3 alkoxy radicals or halogens (F, Cl), it being understood that when one of R.sub.3 and R.sub.4 denotes the radicals: CF.sub.3, N,N-dialkylamino, C.sub.6 H.sub.5 or substituted phenyl, it is present at the vertices 3', 4'or 5' according to formula 1 and the other denotes a hydrogen atom.
R.sub.5 and R.sub.6, (which may be identical or different)=H, halogen (F, Cl, Br), CF.sub.3, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, C.sub.6 H.sub.5, optionally substituted by at most two substitutents which may be identical or different and may denote radicals: C.sub.1-3 alkyl or C.sub.1-3 alkoxy or halogen atoms (F, Cl), on condition that when one of R.sub.5 and R.sub.6 =CF.sub.3, C.sub.6 H.sub.5 or substituted phenyl, it is present at the vertex 6 or 7 and the other denotes a hydrogen atom.
The substitutents R.sub.3 and R.sub.4 or R.sub.5 and R.sub.6 may also together form, on condition of being at two contiguous vertices, diradicals of formulae: --CH.dbd.CH--CH.dbd.CH--, --(CH.sub.2).sub.m -- and --O(CH.sub.2).sub.p O--, in which m=3 or 4, p=1 or 2, it being understood that when R.sub.3 and R.sub.4 or R.sub.5 and R.sub.6 form the chain sequence --O(CH.sub.2).sub.p O--, the latter is linked to the vertices 3' and 4' or 4' and 5' or 6 and 7 according to the formula 1.
R.sub.7 and R.sub.8 =H or, together with the existing C--C bond, form a double bond of trans geometry; R.sub.9 and R.sub.10 =H or together form a C.sub.1-3 dialkylmethylene residue.
In the form of free acids, salts, esters, amides or .delta.-lactones.
Hypocholesterolaemiant, antithrombotic and antifungal medications containing them.
REFERENCES:
Patent Abstacts of Japan vol. 12, No. 33 (C-472)(2880), 30 Janvier 1988; & JP-A-62 181276 (Sagami Chem. Res. Center) 08.08.1987.
Chemical Abstacts vol. 83, No. 8, 25 aout 1975, p. 677, colonne 2, abstract No. 68643f, Columbus, Ohio, U.S.A.; L. Penn et al.: "Chemical Shift Measurements of Substitutent Effects on Out-of-Plane Magnetic Shielding in Benzene Derivatives" & J. Mang. Reson. 1975, vol. 18, No. 1, pp. 6-11.
Chemical Abstracts vol. 76, No. 23, 5 Juin 1972, p. 446, colonne 1, abstract No. 140440n, Columbus, Ohio, U.S.A., J. Degani et al.: "Hetero-Aromatic Cations. XV. Synthesis of some 2-, 3- and 4-aryl derivatives of 1-thianaphthalenium Perchlorate" & Ann. Chim. (Rome) 1971, vol. 61, No. 12, pp. 793-813.
Bellemin Robert
Decerprit Jacques
Descours Denis
Festal Didier
Nioche Jean-Yves
Fan Jane T.
Kilby Scalzo Catherine S.
Lipha Lyonnaise Industrielle Pharmaceutique
LandOfFree
Derivatives of benzocycloalkenyldihydroxyalkanoic acids and medi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of benzocycloalkenyldihydroxyalkanoic acids and medi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of benzocycloalkenyldihydroxyalkanoic acids and medi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-115940